Back to Search Start Over

Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study.

Authors :
Bertani, Giambattista
Santoleri, Luca
Martino, Massimo
Fedele, Roberta
Moscato, Tiziana
Marenco, Paola
Grillo, Giovanni
Zucchetti, Elisa
Lotesoriere, Ivana
Lando, Giuliana
Cesana, Clara
Cairoli, Roberto
Rossini, Silvano
Source :
Transfusion; Aug2014, Vol. 54 Issue 8, p2028-2033, 6p
Publication Year :
2014

Abstract

Background Peripheral blood ( PB) hematopoietic progenitor cells ( HPC) collected by apheresis are the first-choice source for allogeneic stem cell transplantation. The target HPC dose is usually considered to be 4 × 10<superscript>6</superscript> CD34+ cells/kg of the recipient, but higher doses are required in reduced-intensity conditioning and haploidentical transplants. Thus, prolonged stimulation and repeated collections or failure to reach HPC target may occur, increasing risks for donors and recipients. We carried out a retrospective multicenter study on healthy donors, to identify donor variables which may correlate with HPC mobilization. Study Design and Methods HPC allogeneic donations from sibling and unrelated donors performed in two centers from 1995 to 2012 were analyzed. We defined a mobilization cutoff of 50 × 10<superscript>6</superscript> CD34+ cells/ L and tested somatic variables, blood counts, and granulocyte-colony-stimulating factor ( G- CSF) dose and molecular form. Results A total of 360 donors were analyzed (male, 201; female, 159; sibling, 348; unrelated, 12; median [range] age, 44.8 [13-80] years). Median peak CD34+ in PB was 54.4 × 10<superscript>6</superscript>/ L (range, 5 × 10<superscript>6</superscript>-299 × 10<superscript>6</superscript>). By multivariate analysis, we identified the following variables to correlate with good mobilization: 1) male sex (p < 0.0005); 2) younger age (p = 0.007); 3) higher baseline (premobilization) white blood cell ( WBC) count (p < 0.0005); 4) higher G- CSF dosage (p < 0.0005); and 5) use of lenograstim rather than filgrastim (p < 0.002). Conclusion In healthy donors it is possible to predict successful HPC mobilization by donor sex, age, WBC count, and G- CSF form and dose. Furthermore, based on these data, it may be possible, at least in parental setting, to modulate G- CSF dosage on the basis of donor characteristics. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00411132
Volume :
54
Issue :
8
Database :
Complementary Index
Journal :
Transfusion
Publication Type :
Academic Journal
Accession number :
97500547
Full Text :
https://doi.org/10.1111/trf.12612